Both in Pharmaceuticals
Design Therapeutics vs ArriVent BioPharma
Over the past year DSGN returned +90.6% and AVBP returned −2.4%; their daily moves had a correlation of 0.25.
DSGN +90.6% AVBP −2.4%Growth of $1, one year, split-adjusted
| Metric | DSGN | AVBP |
|---|---|---|
| Price | $10.77 | $19.05 |
| Market cap | $673.7M | $939.3M |
| Today | −3.02% | +1.06% |
| 1 month | −18.2% | −37.2% |
| 6 months | −19.5% | −38.3% |
| Year to date | +14.8% | −5.3% |
| 1 year | +84.6% | −4.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $207.4M | $373.1M |
| Dividend yield | — | — |
| Volatility (60d) | 56.2% | 138.8% |
| Short % of float | 21.7% | 25.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).